European Group for Blood and Marrow Transplantation Centers with FACT-JACIE Accreditation Have Significantly Better Compliance with Related Donor Care Standards

Chloe Anthias(Anthony Nolan), Bronwen E. Shaw(Royal Marsden NHS Foundation Trust), Michael A. Pulsipher(Primary Children's Hospital), Maxim Norkin(University of Florida Health), Deidre M. Kiefer(National Marrow Donor Program), Galen E. Switzer(University of Pittsburgh), Brent R. Logan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Menachem Bitan(Tel Aviv Sourasky Medical Center), Paul V. O’Donnell(Johns Hopkins Hospital), Paolo Anderlini(The University of Texas MD Anderson Cancer Center), Bipin N. Savani(Vanderbilt University Medical Center), Miguel Ángel Díaz(Hospital Infantil Universitario Niño Jesús), Jean A. Yared(University of Maryland, Baltimore), Joerg Halter(University Hospital of Basel), Dennis L. Confer(National Marrow Donor Program)
Transplantation and Cellular Therapy
November 18, 2015
10.1016/j.bbmt.2015.11.009
Cited by 26

Related Papers

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy
|Blood|1997|1.2k
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
|Journal of Clinical Oncology|1998|927
Advancing Health Disparities Research Within the Health Care System: A Conceptual Framework
|American Journal of Public Health|2006|763
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age
|Blood|2001|701